-
Table numbers beginning with:
1. contain information about the ED sample and the precision
of the estimates.
2. through 5. contain estimates of ED episodes
and ED drug mentions.
12. through 14. contain corresponding rates per
100,000 population.
Each table of estimates has a corresponding table of rates
per 100,000 population, designated by a 1 prefix added
to the table number. For example, Table 2.3.0 contains estimates
of ED mentions for major substances of abuse; Table 12.3.0 contains
population-based rates of ED mentions for the same major substances
of abuse.
-
Table numbers ending with:
.0 contain estimates for the coterminous U.S.
.1 through .21 contain estimates for the 21 metropolitan
areas oversampled in DAWN, where .1 is Atlanta, .2
is Baltimore, … .21 is Washington, DC (see below).
No third term (e.g., 3.1, 3.2, 13.1, 13.2, etc.): These
tables contain summaries for all the metropolitan areas in DAWN.
For example, Table 3.1 summarizes total ED episodes across the
21 metropolitan areas.
-
RSE tables follow the same numbering scheme, with a
prefix of RSE attached to the companion table number.
For example, Table RSE-2.2.0 contains the RSEs for the estimates
published in Table 2.2.0.
-
Tables 2.3.x through 2.12.x enumerate the specific
substances in 5 categories:
2.3.x and 2.4.x Major substances of abuse
(half year and full year estimates, respectively; e.g., for
cocaine, heroin, marijuana, "club drugs")
2.5.x and 2.6.x Psychotherapeutic agents
(e.g., benzodiazepines)
2.7.x and 2.8.x Central nervous system
(CNS) agents (e.g., narcotic analgesics)
2.9.x and 2.10.x Respiratory agents (e.g.,
antihistamines)
2.11.x and 2.12.x Cardiovascular agents
(e.g., beta-adrenergic blocking agents)
Corresponding population-based rates are found in Tables 12.3.x
through 12.12.x.
-
Tables 3.x (13.x) summarize ED estimates (rates)
across the 21 metropolitan areas.
-
Tables 4.1.x (14.1.x) through 4.34.x (14.34.x)
summarize DAWN ED cases by patient demographics.
-
Tables 5.1.x through 5.34.x summarize DAWN ED
cases by episode characteristics. No population-based rates
are produced for episode characteristics.